Picard Medical / SynCardia Highlights Total Artificial Heart Bridge to Transplant Case at Texas Children's Hospital

TUCSON, Ariz., April 15, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE: PMI ) ("Picard Medical" or the "Company"), parent company of SynCardia Systems, LLC, maker of the world's first total artificial heart approved by both the U.S. FDA and Health Canada, today highlighted the successful use of the SynCardia Total Artificial Heart ("STAH") as a bridge to heart transplantation at Texas Children's Hospital ("Texas Children's"), supporting a 21-year-old patient through a complex re-transplant journey. Texas Children's recently featured the case of Gregory, a now 21-year-old patient who had received his first heart transplant at Texas Children's in 2017 at the age of 13 following multiple congenital heart defects. In early 2025, Gregory was admitted to Texas Children's after presenting with chest pain and was diagnosed with rejection of his first transplanted heart. With his original transplant no longer viable and a donor heart unavailable, surgeons implanted the STAH to provide full circulatory support. Gregory was supported on the STAH for approximately two and a half months before a suitable donor heart became available. He subsequently underwent successful heart transplantation and, following an extended recovery, was discharged from the hospital. The STAH is designed to replace the function of both ventricles in patients with end-stage biventricular failure, enabling stabilization, organ recovery, and improved candidacy for transplantation. Its use in complex clinical scenarios, including re-transplantation in young adults with congenital heart disease, demonstrates the flexibility and durability of the therapy in supporting some of the most critically ill patients. Patrick NJ Schnegelsberg, Chief Executive Officer of Picard Medical, commented, "Performing a successful re-transplantation in a young adult with congenital heart disease is among the most complex scenarios in cardiac surgery. In this instance at Texas Children's, the STAH allowed the clinical team to stabilize the patient and effectively ... Full story available on Benzinga.com